Who Supplies Paclitaxel? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Paclitaxel exports, with 319+ registered manufacturers shipping to buyers across 142+ countries — yet a handful of companies dominate the shipments. FRESENIUS KABI ONCOLOGY LIMITED holds the largest share at 17.9% (export value: $14.8M). Close behind, MSN LABORATORIES PRIVATE LIMITED (6.4%, $5.4M). PANACEA BIOTEC PHARMA LIMITED (6.3%, $5.3M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Paclitaxel? Top Manufacturers & Their Buyers
Flow of Paclitaxel from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Paclitaxel Supplier Network — Key Market Intelligence
The Paclitaxel export market from India is led by FRESENIUS KABI ONCOLOGY LIMITED, which alone commands a 17.9% share, shipping $14.8M worth of product across 854 shipments. The second-largest exporter, MSN LABORATORIES PRIVATE LIMITED, contributes $5.4M (6.4%) to the overall market. Combined, the top two suppliers alone account for 24.3% of all Paclitaxel exports, indicating a relatively concentrated supply base.
Across all 319 tracked manufacturers, the total Paclitaxel export value stands at $83.1M from 4.9K shipments. The market average shipment value is $16.9K. The single largest buyer relationship in terms of trade value is FRESENIUS KABI DEUTSCHLAND GMBH, receiving $12.2M worth of product.
The combined buyer network spans 20 named purchasing companies, including FRESENIUS KABI DEUTSCHLAND GMBH, FRESENIUS KABI COLOMBIA SAS, FRESENIUS KABI THAILAND LTD, AMERICAN HEALTH PACKAGING, NORTHSTAR DISTRIBUTION CENTER 8912, and 15 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1FRESENIUS KABI ONCOLOGY LIMITED
FRESENIUS KABI ONCOLOGY LIMITED is the first-largest Paclitaxel exporter from India, with a market share of 17.9% and a total export value of $14.8M across 854 shipments. Their average shipment value of $17.4K is above the market average of $16.9K, suggesting premium or bulk contract pricing.
FRESENIUS KABI ONCOLOGY LIMITED serves 5 named buyers in our database. FRESENIUS KABI DEUTSCHLAND GMBH is the dominant customer, accounting for 82.0% of this supplier's tracked business. Top customers include:
• FRESENIUS KABI DEUTSCHLAND GMBH — $12.2M across 701 shipments (82.0% of this supplier's total exports)
• FRESENIUS KABI COLOMBIA SAS — $956.4K across 55 shipments (6.4% of this supplier's total exports)
• FRESENIUS KABI THAILAND LTD — $703.6K across 40 shipments (4.7% of this supplier's total exports)
• FRESENIUS KABI THAILAND LTD — $573.1K across 33 shipments (3.9% of this supplier's total exports)
• FRESENIUS KABI THAILAND LTD — $433.7K across 25 shipments (2.9% of this supplier's total exports)
Key Insight: FRESENIUS KABI ONCOLOGY LIMITED's per-shipment value of $17.4K is 3% above the market average of $16.9K, consistent with large-order contracts or value-added formulations.
2MSN LABORATORIES PRIVATE LIMITED
MSN LABORATORIES PRIVATE LIMITED is the second-largest Paclitaxel exporter from India, with a market share of 6.4% and a total export value of $5.4M across 138 shipments. Their average shipment value of $38.8K is above the market average of $16.9K, suggesting premium or bulk contract pricing.
MSN LABORATORIES PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• TO THE ORDER OF — $2.1M across 53 shipments (38.6% of this supplier's total exports)
• AMERICAN HEALTH PACKAGING — $1.4M across 35 shipments (25.5% of this supplier's total exports)
• NORTHSTAR DISTRIBUTION CENTER 8912, — $864.2K across 22 shipments (16.1% of this supplier's total exports)
• NOVADOZ PHARMACEUTICALS LLC — $787.0K across 20 shipments (14.7% of this supplier's total exports)
• NORTHSTAR DISTRIBUTION CENTER 8912, — $269.9K across 7 shipments (5.0% of this supplier's total exports)
Key Insight: MSN LABORATORIES PRIVATE LIMITED's per-shipment value of $38.8K is 130% above the market average of $16.9K, consistent with large-order contracts or value-added formulations.
3PANACEA BIOTEC PHARMA LIMITED
PANACEA BIOTEC PHARMA LIMITED is the third-largest Paclitaxel exporter from India, with a market share of 6.3% and a total export value of $5.3M across 65 shipments. Their average shipment value of $81.1K is above the market average of $16.9K, suggesting premium or bulk contract pricing.
PANACEA BIOTEC PHARMA LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• APOTEX CORP — $2.4M across 30 shipments (45.5% of this supplier's total exports)
• APOTEX INC. — $1.5M across 18 shipments (28.1% of this supplier's total exports)
• APOTEX INC. — $1.2M across 14 shipments (22.0% of this supplier's total exports)
• APOTEX INC - SIGNET — $117.4K across 1 shipments (2.2% of this supplier's total exports)
• M S AGENCIAS Y REPRE — $112.1K across 1 shipments (2.1% of this supplier's total exports)
Key Insight: PANACEA BIOTEC PHARMA LIMITED's per-shipment value of $81.1K is 381% above the market average of $16.9K, consistent with large-order contracts or value-added formulations.
4JODAS EXPOIM PRIVATE LIMITED
JODAS EXPOIM PRIVATE LIMITED is the fourth-largest Paclitaxel exporter from India, with a market share of 3.8% and a total export value of $3.2M across 63 shipments. Their average shipment value of $50.6K is above the market average of $16.9K, suggesting premium or bulk contract pricing.
JODAS EXPOIM PRIVATE LIMITED serves 5 named buyers in our database. OOOJODAS EXPOIM is the dominant customer, accounting for 52.2% of this supplier's tracked business. Top customers include:
• OOOJODAS EXPOIM — $1.7M across 33 shipments (52.2% of this supplier's total exports)
• OOOJODAS EXPOIM — $684.1K across 14 shipments (21.5% of this supplier's total exports)
• OOOJODAS EXPOIM — $456.3K across 9 shipments (14.3% of this supplier's total exports)
• SOFTCARE INTERNATION — $207.7K across 4 shipments (6.5% of this supplier's total exports)
• SOFTCARE INTERNATION — $176.3K across 3 shipments (5.5% of this supplier's total exports)
Key Insight: JODAS EXPOIM PRIVATE LIMITED's per-shipment value of $50.6K is 200% above the market average of $16.9K, consistent with large-order contracts or value-added formulations.
5INTAS PHARMACEUTICALS LIMITED
INTAS PHARMACEUTICALS LIMITED is the fifth-largest Paclitaxel exporter from India, with a market share of 2.4% and a total export value of $2.0M across 405 shipments. Their average shipment value of $4.9K is below the market average of $16.9K, reflecting a high-volume, competitive pricing strategy.
INTAS PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• ACCORD FARMACUTICA LTDA. — $551.2K across 112 shipments (27.8% of this supplier's total exports)
• ACCORD FARMACUTICA LTDA. — $487.8K across 99 shipments (24.6% of this supplier's total exports)
• ACCORD FARMACUTICA LTDA. — $463.3K across 94 shipments (23.3% of this supplier's total exports)
• XXCORXXHEAXXHCAXX B — $241.9K across 49 shipments (12.2% of this supplier's total exports)
• XXcorXXHeaXXhcaXX B — $241.9K across 49 shipments (12.2% of this supplier's total exports)
Key Insight: INTAS PHARMACEUTICALS LIMITED operates with high shipment frequency (405 shipments) at a per-shipment value of $4.9K, indicating a broad distribution network with many smaller, regular orders.
6VENUS REMEDIES LIMITED
VENUS REMEDIES LIMITED is the fifth-largest Paclitaxel exporter from India, with a market share of 1.5% and a total export value of $1.2M across 220 shipments. Their average shipment value of $5.6K is below the market average of $16.9K, reflecting a high-volume, competitive pricing strategy.
VENUS REMEDIES LIMITED serves 5 named buyers in our database. P P is the dominant customer, accounting for 52.5% of this supplier's tracked business. Top customers include:
• P P — $644.4K across 115 shipments (52.5% of this supplier's total exports)
• PHARMAPROM — $189.9K across 34 shipments (15.5% of this supplier's total exports)
• C M C L — $177.2K across 32 shipments (14.4% of this supplier's total exports)
• A S A S — $116.1K across 21 shipments (9.5% of this supplier's total exports)
• U S B — $100.2K across 18 shipments (8.2% of this supplier's total exports)
Key Insight: VENUS REMEDIES LIMITED operates with high shipment frequency (220 shipments) at a per-shipment value of $5.6K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Paclitaxel Flows
Once Paclitaxel leaves the manufacturing plants of companies like FRESENIUS KABI ONCOLOGY LIMITED and MSN LABORATORIES PRIVATE LIMITED, it travels to 5 destination markets with a combined import value of $83.1M. Germany absorbs the largest share at 20.6% ($17.2M), followed by United States (13.1%) and Russia (7.0%).
In Germany — the top destination — named importers include FRESENIUS KABI DEUTSCHLAND GMBH. In United States, key buyers are J. KNIPPER & COMPANY, AMERICAN HEALTH PACKAGING, NORTHSTAR DISTRIBUTION CENTER 8912,.
This geographic spread reflects Paclitaxel's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Paclitaxel Go? Top Importing Countries & Their Buyers
Trade flow of Paclitaxel exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1Germany
Germany ranks as the first-largest destination for Paclitaxel imports from India, with a total trade value of $17.2M across 513 shipments — representing a 20.6% share of all Paclitaxel exports. The average shipment value of $33.4K is above the global average of $16.9K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Paclitaxel importers in Germany: FRESENIUS KABI DEUTSCHLAND GMBH is the largest buyer, accounting for 100.0% ($17.2M) of this market's total imports.
• FRESENIUS KABI DEUTSCHLAND GMBH — $17.2M (100.0% of Germany's total)
Key Insight: Germany's per-shipment average of $33.4K (98% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Germany is a key market for Paclitaxel imports from India.
2United States
United States ranks as the second-largest destination for Paclitaxel imports from India, with a total trade value of $10.9M across 96 shipments — representing a 13.1% share of all Paclitaxel exports. The average shipment value of $113.4K is above the global average of $16.9K, indicating high-value procurement contracts or branded formulations. This market is served by 5 tracked buyers.
Named Paclitaxel importers in United States: J. KNIPPER & COMPANY is the largest buyer, accounting for 17.1% ($1.9M) of this market's total imports.
• J. KNIPPER & COMPANY — $1.9M (17.1% of United States's total)
• AMERICAN HEALTH PACKAGING — $1.4M (12.5% of United States's total)
• NORTHSTAR DISTRIBUTION CENTER 8912, — $864.2K (7.9% of United States's total)
Key Insight: United States's per-shipment average of $113.4K (573% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Paclitaxel imports from India.
3Russia
Russia ranks as the third-largest destination for Paclitaxel imports from India, with a total trade value of $5.9M across 35 shipments — representing a 7.0% share of all Paclitaxel exports. The average shipment value of $167.2K is above the global average of $16.9K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Paclitaxel importers in Russia: OOO"JODAS EXPOIM" is the largest buyer, accounting for 44.8% ($2.6M) of this market's total imports.
• OOO"JODAS EXPOIM" — $2.6M (44.8% of Russia's total)
• OOOJODAS EXPOIM — $1.7M (28.4% of Russia's total)
• OOO JODAS EXPOIM — $722.9K (12.4% of Russia's total)
Key Insight: Russia's per-shipment average of $167.2K (892% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Russia is a key market for Paclitaxel imports from India.
4Canada
Canada ranks as the fourth-largest destination for Paclitaxel imports from India, with a total trade value of $5.8M across 35 shipments — representing a 7.0% share of all Paclitaxel exports. The average shipment value of $166.6K is above the global average of $16.9K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Paclitaxel importers in Canada: APOTEX CORP is the largest buyer, accounting for 41.1% ($2.4M) of this market's total imports.
• APOTEX CORP — $2.4M (41.1% of Canada's total)
• APOTEX INC. — $1.5M (25.4% of Canada's total)
• APOTEX INC — $1.2M (19.9% of Canada's total)
Key Insight: Canada's per-shipment average of $166.6K (888% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Canada is a key market for Paclitaxel imports from India.
5Thailand
Thailand ranks as the fifth-largest destination for Paclitaxel imports from India, with a total trade value of $4.7M across 12 shipments — representing a 5.6% share of all Paclitaxel exports. The average shipment value of $388.4K is above the global average of $16.9K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Paclitaxel importers in Thailand: FRESENIUS KABI (THAILAND) LTD., is the largest buyer, accounting for 16.7% ($777.9K) of this market's total imports.
• FRESENIUS KABI (THAILAND) LTD., — $777.9K (16.7% of Thailand's total)
• FRESENIUS KABI THAILAND LTD — $703.6K (15.1% of Thailand's total)
Key Insight: Thailand's per-shipment average of $388.4K (2203% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Thailand is a key market for Paclitaxel imports from India.
People Also Ask — Paclitaxel Supplier & Trade Network
Who are the top suppliers of Paclitaxel from India?+
Which companies buy Paclitaxel from Indian manufacturers?+
Where does Paclitaxel exported from India go?+
What is the market share of the top Paclitaxel supplier from India?+
What is the average shipment value for Paclitaxel exports from India?+
Is Paclitaxel manufactured in India and exported globally?+
Which country imports the most Paclitaxel from India?+
Who are the buyers of Paclitaxel in United States?+
How concentrated is the Paclitaxel supplier market in India?+
How do I find verified buyers for Paclitaxel in specific countries?+
Paclitaxel Trade Network — Key Takeaways
- 1FRESENIUS KABI ONCOLOGY LIMITED is India's dominant Paclitaxel exporter with a 17.9% market share and $14.8M in total exports — making it the single most important sourcing entity in this market.
- 2The top 319 suppliers collectively account for 38.4% of all tracked Paclitaxel exports, with a combined trade value of $83.1M.
- 3Germany is the largest destination market, absorbing 20.6% of India's Paclitaxel exports ($17.2M). United States (13.1%) and Russia (7.0%) follow.
- 4With 4.9K total shipments averaging $16.9K each, the Paclitaxel export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include FRESENIUS KABI DEUTSCHLAND GMBH, FRESENIUS KABI COLOMBIA SAS, AMERICAN HEALTH PACKAGING, NORTHSTAR DISTRIBUTION CENTER 8912, — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 142 countries
Network value: $83.1M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Paclitaxel — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Paclitaxel.
- 2.Flow Mapping: 319 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 4,928 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 142 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
4,928 Verified Shipments
319 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists